- Issuer ticker
-
RVMD
- Reported as of
-
13 Nov 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
17 Nov 2026, 18:00:07 UTC
Filing notes and source
Key filing fact
Flavia Borellini filed Form 4 for Revolution Medicines, Inc. (RVMD) on 17 Nov 2026.
Key facts
- This page summarizes Flavia Borellini's Form 4 filing for Revolution Medicines, Inc. (RVMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Nov 2026, 18:00.
Change
- Previous filing in this sequence was filed on 13 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001867426
Primary reporting owner
Borellini Flavia
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVMD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,500
- Change %
- +9.5%
- Price
-
$37.54*
- Shares after
- 28,715
- Date
- 13 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RVMD
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -2,500
- Change %
- -16%
- Price
-
$0.000000*
- Shares after
- 13,455
- Date
- 13 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $37.54
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes